This is a $3,947,011.00 cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, operating as the Defence Science and Technology Laboratory (DSTL). The contract is for a research and development effort focused on using virus-like particles as a novel platform for delivering protective antigens against Burkholderia bacteria. The contract does not have a set-aside designation. DSTL is a...
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as the Defence Science and Technology Laboratory (DSTL), a United Kingdom government entity. The contract, valued at $4,226,739.50, supports the "BASE PERIOD - AD92" requirement and has an ultimate completion date of June 26, 2021. The contract is not designated as a set-aside. The award is part of a larger Indefinite Delivery Contract...
This is a $2,758,080.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (doing business as D S T L), a United Kingdom government entity. The contract is for the project "HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR)" and has a March 30, 2023 completion date. The contract was awarded on December 10, 2018 and was not set aside for any special designation. D S T L, as a foreign government...
This is a cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, operating as the Defence Science and Technology Laboratory (DSTL). The $1,104,374.25 contract is for diagnostic meta-analysis research, with a period of performance ending on September 30, 2021. As a foreign government entity, DSTL has a proven track record of securing contracts from U.S. federal agencies, including DTRA and the...
This is a $6,400,448.87 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence of the United Kingdom, doing business as the Defence Science and Technology Laboratory (D S T L). The contract is for the development of non-ionic surfactant vesicles (NISVs) as a drug delivery and targeting system for antimicrobials. This contract was awarded under a Broad Agency Announcement (BAA) that solicited proposals for innovative research and...
The Defense Threat Reduction Agency awarded a $4,387,571.00 Cost Plus Fixed Fee contract to the Ministry of Defence, doing business as D S T L, a U.K. government entity located in Great Britain. The contract is for the development of chemical and biological decision support tools, with a completion date of July 21, 2022. The work supports U.S. defense and homeland security efforts to counter emerging biological and chemical threats, and may involve activities such as research on medical...
This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Memed Diagnostics LTD, a for-profit limited liability company located in Israel. The contract has a ceiling value of $10,373,294.17 and is a cost-plus-fixed-fee definitive contract with a period of performance ending on September 30, 2020. The contract was awarded on January 1, 2017 and was not set aside. The purpose of the contract is not provided, but DTRA's mission is to counter and deter...
This is a $5,570,766.33 delivery order awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to the UK Health Security Agency, formerly known as Public Health England. The contract is for biological animal model and medical countermeasure development services to support the Biomedical Advanced Research and Development Authority's (BARDA) efforts to combat chemical, biological, radiological, and nuclear threats....
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to a prime contractor for R&D, Other Services, and Advanced Development services. The contract has a ceiling value of $1,212,120.00 and was awarded on September 15, 2002, with a final completion date of December 31, 2007. The contract is a definitive contract with an "Other" pricing type and does not have a set-aside designation. The place of performance is...
This federal contract award, valued at $1,802,359.68, was made by the Defense Threat Reduction Agency (DTRA) to the University of South Alabama (USA) for the development of "antigenically defined vaccines for immunization against melioidosis and glanders." This is a definitive, cost-type contract with no set-aside designation. The University of South Alabama has extensive experience in executing federal contracts and grants, and this award is part of a larger $146.3 million...